Table 1 Demographic data and clinical features of AKI associated MIS-C, related COVID-19

Age (year) ^a

7.5 (0.75–17)

9 (5–14)

0.464

Gender ^b (Male/female)

19 (61.3%)/12 (38.7%)

6 (54.5%)/ 5 (45.5%)

0.695

Weight (kg) ^a

23 (7.3–71)

22.5 (13–39)

0.308

Height (cm) ^c

121.1 ± 31.5

123.5 ± 25.9

0.818

BMI (kg/m²) ^c

18.8 ± 3.8

14.7 ± 1.5

0.002

Presenting features ^b

 Fever

27 (87.1%)

9 (81.8%)

0.667

 Dyspnoea

25 (80.6%)

11 (100%)

0.115

 GIT symptoms

17 (54.8%)

6 (54.5%)

0.987

 Rash

3 (9.7%)

0

0.284

MIS-C associating AKI ^b

 Cardiac

11 (35.5%)

2 (18.2%)

0.286

 Respiratory

25 (80.6%)

11 (100%)

0.115

 Gastro-intestinal

9 (29%)

0

0.044

 Hematologic

23 (74.2%)

7 (63.6%)

0.505

 Neurologic

10 (32.3%)

0

0.031

 Dermatologic

3 (9.7%)

0

0.284

 Vasopressors use ^b

5 (16.1%)

1 (9.1%)

0.567

 Oxygen therapy ^b

15 (48.4%)

9 (81.8%)

0.054

 Invasive Mechanical Ventilation b

13 (41.9%)

2 (18.2%)

0.158

 Duration of Mechanical Ventilation c

7.3 ± 3.3

8 ± 1.4

0.785

 Duration of PICU stay (days)^c

(n = 21). 9.9 \(\pm\) 5.2

(n = 4). 8.5 \(\pm\) 3.1

0.624

 Duration of hospital stay (days)^c

23.6 \(\pm\) 12.8

13.5 \(\pm\) 9.3

0.021